Mahfoud F, Sievert H, Bertog S, Lauder L, Ewen S, Lengele JP, Wojakowski W, Schmieder R, Van Der Giet M, Weber MA, Kandzari DE, Parise H, Fischell TA, Pathak A, Persu A (2021)
Publication Type: Journal article
Publication year: 2021
Book Volume: 14
Journal Issue: 9
DOI: 10.1161/CIRCINTERVENTIONS.120.010075
BACKGROUND: Primary results of this prospective, open-label, multicenter trial suggested that alcohol-mediated renal denervation with perivascular injection of dehydrated alcohol using the Peregrine System Infusion Catheter safely reduces blood pressure (BP) in patients with resistant hypertension. To date, maintenance of the BP-lowering effect beyond 6 months using this novel technology has not been reported. This article describes the final, 12-month follow-up data on the safety and efficacy of alcohol-mediated renal denervation in these patients.
APA:
Mahfoud, F., Sievert, H., Bertog, S., Lauder, L., Ewen, S., Lengele, J.-P.,... Persu, A. (2021). Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension. Circulation: Cardiovascular Interventions, 14(9). https://doi.org/10.1161/CIRCINTERVENTIONS.120.010075
MLA:
Mahfoud, Felix, et al. "Long-Term Results up to 12 Months After Catheter-Based Alcohol-Mediated Renal Denervation for Treatment of Resistant Hypertension." Circulation: Cardiovascular Interventions 14.9 (2021).
BibTeX: Download